北京招聘

Reporting to: Hanovia Industry Manager of Greater China

Main purpose(s) of job: To maintain and further develop hanovia UV business in China Pharma market.

Key contacts: Internal – Sales and Marketing staff are in China, USA region and in Hanovia head office (UK)

External – Distributors, customers, Halma group companies, industry associations & consultants, Government bodies, etc.

Location: Based at Tianjin or Hebei, Home office. China and overseas travel may be required.

Working hours: Normal business hours plus other reasonable time as required to meet the job requirements. This job does not attract overtime payments.

Key responsibilities

Achievement of sales budget and any other agreed KPIs.

Annual and monthly business forecasting.

Identify sales prospects and contact these and other accounts as assigned.

Present and sell company products and services to customers.

Prepare quotes and technical solutions to customer requirements.

Follow up on new and existing opportunities, and record all such activity and opportunity status in the company CRM system.

Develop and maintain current product knowledge.

To actively seek out market information on competitors, customers and market trends and to input this information into the company CRM system.

To prepare reports including sales activity, sales won/lost with reasons, follow-up activity, and any other reports as required by your manager.

Participate in events such as seminars, trade shows, and telemarketing events.

Other duties:

Provide cover for other China Sales team staff sickness, holiday, or other absences.

Answer and professionally handle incoming calls to the sales office.

Evaluate other potential application of UV in water treatment.

Where required, to travel to customers’ sites throughout China to provide field based technical support.

Maintain full technical records of all test both in the laboratory and in the customer site.

Any other reasonable duties as required.

Candidate profile

Openness, honesty, integrity, independently

A minimum of a Junior College level qualification.

A track record of successful experience in capital equipment to China Pharma market.

A minimum of 2 years sales experience, with a good understanding of China Pharma market.

IT “enthusiast” – highly literate in Internet/PC / Windows / MS Office.

Experience of CRM systems – preferably SalesLogix.

Good communicator – ability to interface with all levels in the company.

Ability and independently to undertake national and international business travel, including Hanovia booths at trade events. Willing to spend up to 50% of time travelling.

Fluent in written Mandarin - fluent means being able to hold business meetings, sales negotiations, public presentations, etc in the language

The following are highly desirable characteristics:

Qualification in marketing or marketing communications

Knowledge of water treatment market would be an advantage.

Good at reading and written English.

About Halma

Halma plc is a global group of life-saving technology companies. Our innovative products and solutions address many of the key issues facing the world today. Together, we have a purpose that drives everything we do: Growing a safer, cleaner, healthier future for everyone, every day.

Our purpose defines the three broad market areas where we operate:
Safety: protecting life as populations grow and urbanise and protecting worker safety.
Environment: improving food and water quality, and monitoring air pollution.
Health: meeting rising healthcare demand as growing populations age and lifestyles change.

We employ over 7,000 people in 20 countries, with major operations in the UK, Europe, the USA and Asia Pacific. Halma is listed on the London Stock Exchange and has been a member of the FTSE 100 index since December 2017.




关于豪迈
豪迈是一家致力于生命安全技术的全球性集团。我们的创新产品和解决方案解决当今世界面临的诸多关键问题。我们的宗旨推动我们所做的一切：每一天都致力于为每个人创造一个更安全、更清洁、更健康的未来。

我们的宗旨定义了我们经营的三大市场领域：
安全：在人口增长和城市化进程中保障生命和工作人员安全。
环境：改善食品和水质，监测空气污染。
健康：随着人口老龄化和生活方式的改变，满足日益增长的医疗需求。

我们在20个国家拥有7000多名员工，主要业务遍及英国、欧洲、美国和亚太地区。豪迈在伦敦证券交易所上市，自2017年12月以来一直是英国富时100指数的成分股。